Skip to content
    Real-World Studies

    Smoking Status and Survival Outcomes in Solid Cancers: A Multivariable Cohort Study

    Heervä et alESMO real world data and digital oncology

    Smoking Status and Survival Outcomes in Solid Cancers: A Multivariable Cohort Study
    In a population-based cohort study of patients diagnosed with solid cancers (ICD-10 codes C00–C43, C45–C68) treated at two Finnish university hospitals between 2009 and 2019, smoking status was evaluated for its association with overall survival (OS) and cancer-specific survival (CSS). Smoking status (never, former, or current) was determined from medical records using a natural language processing pipeline and linked to nationwide mortality registries. Among 62,893 identified patients, smoking status was documented in 45,395 individuals (72%). Kaplan-Meier estimates showed 5-year OS rates of 71% in never smokers, 58% in former smokers, and 49% in current smokers. After adjusting for age, sex, performance status, comorbidity, nodal status, and treatment intent in multivariable Cox regression models, the hazard ratio for OS was 1.48 (95% CI, 1.43–1.53) for former smokers and 1.91 (95% CI, 1.85–1.97) for current smokers relative to never smokers. Cancer-specific mortality was similarly elevated, with adjusted HRs of 1.52 (95% CI, 1.47–1.59) in former smokers and 2.09 (95% CI, 2.02–2.17) in current smokers. Five-year CSS was 4% to 19% lower among current versus never smokers across most evaluated tumor sites, with risk increases across cancer types ranging from HR 1.15 to 3.96 for OS and HR 1.12 to 4.07 for CSS. These associations persisted in the subgroup of 36,936 patients treated with curative intent. The authors conclude that these findings support the systematic implementation of smoking assessment and cessation interventions within oncology practice.

    Key Takeaways

    • In a population-based cohort of 45,395 patients with solid tumors, 5-year overall survival was 71% for never smokers compared with 58% for former smokers (adjusted HR 1.48; 95% CI, 1.43–1.53) and 49% for current smokers (adjusted HR 1.91; 95% CI, 1.85–1.97).
    • Five-year cancer-specific survival was 4% to 19% lower in current versus never smokers across most cancer types, with multivariable-adjusted cancer-specific mortality elevated in both former (HR 1.52; 95% CI, 1.47–1.59) and current smokers (HR 2.09; 95% CI, 2.02–2.17), persisting within the curative-intent subgroup (n = 36,936).
    Read the original sourceESMO real world data and digital oncology